World’s largest study of long COVID will evaluate potential therapies for brain fog, sleep disruption and more.
The US National Institutes of Health (NIH) announced yesterday that it will launch its first trials to test the safety and efficacy of treatments against long COVID. These trials will focus on therapies aimed at some of the most debilitating symptoms of the disease, including brain fog and disturbed sleep.
Click the link below to read the full article published by Nature.
NIH launches trials for long-COVID treatments: what scientists think (nature.com)
